It is important to keep up and do you due diligence.
It is hard to keep up with all the message board memes around here such as DCVax'-L being used as SOC in any trial.
Comparing A to A+B in an early stage trial does not mean A is being used as SOC. It is used to see if A+B is reasonable to advance into later stage trials.
Liau has no active trials other than the P3. We will have to see what, if any, shows up.
Market Data 
Markets 
